Anthera Pharma (ANTH) Misses Q1 EPS by 1c
Tweet
Share
E-mailGet Alerts ANTH Hot Sheet
Join SI Premium – FREE
Anthera Pharma (NASDAQ: ANTH) reported Q1 EPS of ($0.29), $0.01 worse than the analyst estimate of ($0.28).
For earnings history and earnings-related data on Anthera Pharma (ANTH) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Synopsys upgraded at Piper Sandler on Intel foundry momentum, Apple opportunity
- Primoris cuts 2026 outlook on renewables cost overruns, COO exits
- BofA lists top 5 themes driving next $1tn in incremental semi sales
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
